The following is a summary of “Association of Glucagon-like Peptide-1 Receptor Agonists with Optic Nerve and Retinal Adverse ...

The two drugs are metformin, one of the most widely used diabetes medications, and the GLP-1 class of medications that include Ozempic, Mounjaro and Saxenda. A study of nearly 13,000 people with ...

glucagon-like peptide (GLP)-1 receptor agonist, or dipeptidyl peptidase-4 (DPP-4) inhibitor added to metformin, reported José Luchsinger, MD, MPH, of Columbia University Irving Medical Center in ...

A study has found a higher risk of suicidal thoughts in users of Novo Nordisk's GLP ... was 1.45 times more likely to mention suicidal ideation compared to patients on dapagliflozin, metformin ...

GLP-1RA use initially lowered delirium risk but eventually heightened delirium risk after 5 years among patients with type 2 diabetes.

Shares of Novo Nordisk Inc. (NYSE: NVO) are trading lower Tuesday after a new study raised concerns about a potential link ...

Humans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy may be generating ...

A new study finds a link between the use of antidiabetic drugs like SGLT2 inhibitors and a reduced risk for atrial ...

Losing weight and sustaining a healthy weight are notoriously difficult. If you’re struggling to reach your weight goals, you ...

Semaglutide use may be increasing worldwide rates of ischemic optic neuropathy and retinal adverse events, a study suggests.

Ozempic is FDA-approved for treating type 2 diabetes – but could it also help with other conditions like PCOS Read on to find out what an expert says ...